Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy-Reference-Cited by-同舟云学术

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy

Published:2024-04 Issue:2 Volume:14 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Steinbacher Donna¹,Murray Brian²^ORCID,Devlin Thomas³,Carson Shannon S.⁴,Ford H. James⁵

Affiliation:

1. Department of Pharmacy University of North Carolina Health Chapel Hill North Carolina USA

2. Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora Colorado USA

3. Department of Respiratory Therapy University of North Carolina Health Chapel Hill North Carolina USA

4. University of North Carolina School of Medicine Chapel Hill North Carolina USA

5. Pulmonary Hypertension Program University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

Abstract

AbstractProstacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life‐threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12396

Reference10 articles.

1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Pulmonary hypertension inhaled therapies: An updated review

3. BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension

4. An Observational Study of Inhaled‐Treprostinil Respiratory‐Related Safety in Patients with Pulmonary Arterial Hypertension

5. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-09-07